Shamir medical center

Be’er Ya‘aqov 7030000

1 studies enrolling now · 10 studies all time

What they study most

Atherosclerosis, Extreme Prematurity, Geographic Atrophy, Idiopathic Pulmonary Fibrosis, Late-Onset Neonatal Sepsis, Macular Degeneration, Myelofibrosis, Neonatal Hypotension, Parkinson´s Disease, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis — Recruiting now
• Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling
• Rostock International Parkinson's Disease Study (ROPAD) — Completed
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
• Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments — Running, not enrolling
• IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact — Running, not enrolling
• A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy — Completed